NGeneBio

354200 · KOSDAQ · Industrials · SMALL CAP

Early redemption of convertible bonds (incl. overseas CBs)

ENGEN BIO acquired convertible bonds (4th series) before maturity on 2026-09-18 for US$1.82M (including principal and interest), with a face value of US$1.74M, through mutual agreement with bondholders for early redemption, with the bonds to be cancelled. The bonds were originally issued on 2024-06-14 with a maturity date of 2029-06-14 and a conversion price of US$3.88 per share.

Capital raise(Early redemption of convertible bonds (incl. overseas CBs))· FILED 2026-09-18· RCEPT 20260918900375

What happened

ENGEN BIO / Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity Following Issuance / (2026.09.18)

Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity Following Issuance Convertible Bonds (Overseas Convertible Bonds) - 4th Series

1. Matters Concerning Pre-Maturity Acquisition of Bonds Bond Type: Bearer-form, Interest-bearing, Unsecured, Private Placement Convertible Bonds Issuance Date: 2024-06-14 Issuance Method: Domestic Issuance (Private Placement) Conversion Price per Share (KRW): 5,354 Maturity Date: 2029-06-14

2. Bond Acquisition Amount Currency: KRW (South Korean Won) Acquisition Amount: 2,510,733,600 Face Value (Electronic Registration) Total of Acquired Bonds: 2,400,000,000 KRW Benchmark Exchange Rate: - Acquisition Date: 2026-09-18

3. Face Value (Electronic Registration) Total of Bonds After Acquisition Currency: KRW (South Korean Won) Amount: 0

4. Reason for Pre-Maturity Acquisition and Future Treatment Method 1) Reason for Acquisition: Early redemption by mutual agreement with bondholders 2) Future Treatment Method: Cancellation

5. Source of Acquisition Funds Own funds

6. Method of Bond Acquisition Over-the-counter purchase

7. Other Matters for Reference in Investment Decisions - The bond acquisition amount stated in Section 2 above includes principal and interest. - The acquisition date stated in Section 2 above is the date on which the acquisition amount was remitted to the bondholder who requested early redemption. - The conversion price per share stated above is the current conversion price as of the present date.

Related Disclosures: 2024-06-03 Convertible Bond Issuance Decision (4th Series) 2024-06-04 Convertible Bond Issuance Decision (4th Series) 2024-06-14 Securities Issuance Results (Voluntary Disclosure) (4th Series CB) 2025-06-16 Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity Following Issuance 2026-02-03 Decision to Sell Own Convertible Bonds (4th Series) 2026-02-06 Exercise of Conversion Rights

Filed2026-09-18, Early redemption of convertible bonds (incl. overseas CBs)
SourceDART rcept 20260918900375 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-18 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).